DNA methylation-associated colonic mucosal immune and defense responses in treatment-naïve pediatric ulcerative colitis
R. Alan Harris(Baylor College of Medicine), Richárd Kellermayer(Baylor College of Medicine), Antone R. Opekun(Baylor College of Medicine), Sabina Mir(Baylor College of Medicine), Jess L. Kaplan(Massachusetts General Hospital), Dorottya Nagy‐Szakal(Baylor College of Medicine), George D. Ferry(Baylor College of Medicine), Jiří Bronský(Charles University), Eibe Frank(University of Waikato), Harland S. Winter(Harvard University), Réka Szigeti(Baylor College of Medicine)
Cited by 76
Related Papers
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease
|Journal of Crohn s and Colitis|2014|1.1k
Induction and Maintenance Infliximab Therapy for the Treatment of Moderate-to-Severe Crohn’s Disease in Children
|Gastroenterology|2006|872
Evaluation, Diagnosis, and Treatment of Gastrointestinal Disorders in Individuals With ASDs: A Consensus Report
|PEDIATRICS|2010|870
Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study
|The Lancet|2017|647
Children with early-onset inflammatory bowel disease (IBD): Analysis of a pediatric IBD consortium registry
|The Journal of Pediatrics|2005|571